Company intelligence / Profile preview

Penicillin

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Penicillin is a healthcare venture studio founded in 2023 by TJ Parker and Elliot Cohen, the co-founders of PillPack. The company focuses on building and launching new healthcare and life sciences companies from the ground up, leveraging the founders' extensive experience in scaling healthcare technology and pharmacy services. Penicillin aims to address systemic challenges in the healthcare industry by developing innovative business models and infrastructure. The studio provides capital, strategic guidance, and operational support to its portfolio companies to accelerate their path to market. By focusing on high-impact areas such as patient care delivery and healthcare logistics, Penicillin seeks to modernize the patient experience.

Industry: Investors

Beyond the preview

Go deeper on Penicillin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin.

Explore the full profile